Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform Life Science Investing
Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000 Genetics Investing
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration Life Science Investing
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Life Science Investing
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares Life Science Investing
AbbVie Announces Topline Results for Epcoritamab from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Pharmaceutical Investing
